Credit Suisse Ag Novavax Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Novavax Inc stock. As of the latest transaction made, Credit Suisse Ag holds 405,846 shares of NVAX stock, worth $3.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

405,846

Previous 452,777 10.37%

Holding current value

$3.53 Million

Previous $2.17 Million 10.77%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$3.76 - $6.02 $176,460 - $282,524	-46,931 Reduced 10.37%	405,846 $1.94 Million
Q4 2023 Feb 08, 2024	BUY	$4.8 - $7.67 $571,824 - $913,727	119,130 Added 35.71%	452,777 $2.17 Million
Q3 2023 Nov 13, 2023	SELL	$6.81 - $9.74 $705,781 - $1.01 Million	-103,639 Reduced 23.7%	333,647 $2.42 Million
Q2 2023 Aug 11, 2023	BUY	$6.67 - $9.52 $1.01 Million - $1.45 Million	151,828 Added 53.19%	437,286 $3.25 Million
Q1 2023 May 10, 2023	SELL	$5.76 - $12.48 $2.28 Million - $4.94 Million	-395,467 Reduced 58.08%	285,458 $1.98 Million
Q4 2022 Feb 13, 2023	SELL	$8.86 - $25.04 $2.28 Million - $6.44 Million	-257,378 Reduced 27.43%	680,925 $7 Million
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $11 Million - $46.2 Million	606,480 Added 182.77%	938,303 $17.1 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $6.76 Million - $14 Million	186,228 Added 127.91%	331,823 $17.1 Million
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $1.6 Million - $3.27 Million	-22,875 Reduced 13.58%	145,595 $10.7 Million
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $15.3 Million - $24.7 Million	-113,525 Reduced 40.26%	168,470 $24.1 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $16.2 Million - $24.7 Million	91,309 Added 47.88%	281,995 $58.5 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $12.1 Million - $25.7 Million	99,822 Added 109.86%	190,686 $40.5 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $17.2 Million - $48.7 Million	-152,112 Reduced 62.6%	90,864 $16.5 Million
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $13.3 Million - $23.5 Million	168,329 Added 225.5%	242,976 $27.1 Million
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $1.49 Million - $3.35 Million	-18,787 Reduced 20.11%	74,647 $8.09 Million
Q2 2020 Aug 12, 2020	BUY	$13.86 - $83.61 $1.29 Million - $7.81 Million	93,434 New	93,434 $7.79 Million
Q4 2019 Feb 12, 2020	SELL	$3.69 - $5.22 $216,436 - $306,179	-58,655 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.02 - $7.84 $68,721 - $134,024	17,095 Added 41.13%	58,655 $294,000
Q2 2019 Aug 14, 2019	BUY	$4.93 - $12.2 $204,890 - $507,031	41,560 New	41,560 $244,000

Others Institutions Holding NVAX

# of Institutions

290

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account